• Corpus ID: 13445481

Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.

  title={Efficacy and safety of 3\% minoxidil versus combined 3\% minoxidil / 0.1\% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.},
  author={Chuchai Tanglertsampan},
  journal={Journal of the Medical Association of Thailand = Chotmaihet thangphaet},
  volume={95 10},
  • C. Tanglertsampan
  • Published 1 October 2012
  • Medicine
  • Journal of the Medical Association of Thailand = Chotmaihet thangphaet
BACKGROUND Topical minoxidil and oral finasteride have been used to treat men with androgenetic alopecia (AGA. [] Key Method Efficacy was evaluated by hair counts and global photographic assessment. Safety assessment was performed by history and physical examination. RESULTS At week 24, hair counts were increased from baseline in both groups. However paired t-test revealed statistical difference only in MFX group (p = 0.044). Unpaired t-test revealed no statistical difference between two groups with…

Tables from this paper

Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study

A topical combination of 0.25% finasteride and 3% minoxidil may be a promising option in the treatment of FPHL with an additional benefit of increasing hair diameter, Nevertheless, as it may be absorbed percutaneously, it should be reserved for postmenopausal women.

A Comparative Study between Topical 5 % Minoxidil and Topical “ Redensyl , Capixyl , and Procapil ” Combination in Men with Androgenetic Alopecia

The RCP group showed a significantly better clinical recovery in terms of hair growth, and patients treated with RCP had a significantly higher researcher score, higher global photographic evaluation score, and higher self-evaluation score.

A New Topical Formulation of Minoxidil and Finasteride Improves Hair Growth in Men with Androgenetic Alopecia

Topical formulation of MorrF was shown to have clinically significant improvement in terms of hair growth as compared to Minoxidil (5%) alone and was found to be well-tolerated in rats and humans.

The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis

In patients with AGA, the combination treatment of finasteride and topical minoxidil has better therapeutic efficacy than and similar safety as monotherapy, however, the best concentration of combination treatment requires further studies with sound methodological quality.

Minoxidil 2% lotion for eyebrow enhancement: A randomized, double‐blind, placebo‐controlled, spilt‐face comparative study

It is suggested that minoxidil 2% lotion is a safe and effective treatment for eyebrow hypotrichosis.

A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.

Preliminary results on the use of topical FNS are limited, but safe and promising, and continued research into drug-delivery, ideal topical concentration and application frequency, side effects, and use for other alopecias will help to elucidate the full extent oftopical FNS' use.

Review of selected endpoints in studies evaluating the effectiveness and efficacy of topical finasteride use for androgenetic alopecia

This review highlighted the available tools of hair evaluation in the reviewed literature and found assessment methods were inconsistently applied across the reviewed studies, which led to results that are hard to combine statistically.

The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta‐analysis

It is suggested that combination therapy could be an effective, safe and promising option for the treatment of AGA, however, more RCTs are needed to further investigate and confirm the efficacy of combined treatment.

A randomized, double‐blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia

The synergism of combined use between oral finasteride and topical minoxidil has been established in treating androgenetic alopecia among men. However, the concern regarding adverse effects of

What’s New in Therapy for Male Androgenetic Alopecia?

The pipeline of potential new treatments for male androgenetic alopecia is strong, and Pyrilutamide and GT20029 are being studied as topical antagonists of the androgen receptor, while cetirizine is another topical option with some initial promising results.



Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course

The clinical outcome, in terms of both hair regrowth and balding areas reduction, seems to be encouraging, in the absence of either any evidence of percutaneous absorption of finasteride, or local/systemic untoward effects.

Persistent sexual side effects of finasteride for male pattern hair loss.

The types and duration of sexual dysfunction and the changes in perceived sexual frequency and sexual dysfunction score between pre- and post-finasteride use are characterized.

Possibilities and Limitations for Reversal of Age-Related Hair Loss

This chapter discussed the management and treatment option of different forms of age-related hair loss, which can reveal the aging process, and some inflammatory scalp diseases typically occur in older patients.

Androgenetic alopecia.

Evaluation and treatment of male and female pattern hair loss.

Randomized double-blind placebo controlled trial in the treatment of male androgenetic alopecia with 0.1% finasteride solution

  • Jpn J Dermatol
  • 2003

Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia.

The therapeutic effects of bothfinasteride gel and finasteride tablet were relatively similar to each other, and Serial measurements indicated a significant increase in hair counts and terminal hair counts between the two groups.

Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism

Low-level light therapy (LLLT) has recently been approved by the United States Food and Drug Administration for the treatment of hair loss and there are several theories and minimal clinical evidence of the safety and efficacy, although most experts agree that it is safe.

Androgenetic alopecia: pathogenesis, clinical features and practical medical treatment

  • J Med Assoc Thai Vol
  • 2012